Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
78
CW Quote, Financials, Valuation and Earnings
Last price:
$440.09
Seasonality move
:
2.38%
Day range:
$435.35 - $441.41
52-week range:
$258.85 - $453.02
Dividend yield:
0.19%
P/E ratio:
39.16x
P/S ratio:
5.24x
P/B ratio:
6.48x
Volume:
440.3K
Avg. volume:
290.2K
1-year change:
57.68%
Market cap:
$16.6B
Revenue:
$3.1B
EPS (TTM):
$11.24
Analysts' Opinion
-
Consensus RatingCurtiss-Wright has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $408.26, Curtiss-Wright has an estimated downside of -7.24% from its current price of $440.11.
-
Price Target UpsideAccording to analysts, the highest upside price target is $500.00 representing -100% upside increase from its current price of $440.11.
Fair Value
-
According to the consensus of 8 analysts, Curtiss-Wright has -7.24% downside to fair value with a price target of $408.26 per share.
CW vs. S&P 500
-
Over the past 5 trading days, Curtiss-Wright has overperformed the S&P 500 by 3.87% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Curtiss-Wright does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Curtiss-Wright has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Curtiss-Wright reported revenues of $805.6M.
Earnings Growth
-
Curtiss-Wright has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Curtiss-Wright reported earnings per share of $2.68.
Enterprise value:
17.3B
EV / Invested capital:
--
Price / LTM sales:
5.24x
EV / EBIT:
29.23x
EV / Revenue:
5.39x
PEG ratio (5yr expected):
2.49x
EV / Free cash flow:
35.60x
Price / Operating cash flow:
34.59x
Enterprise value / EBITDA:
24.60x
Gross Profit (TTM):
$1.2B
Return On Assets:
8.89%
Net Income Margin (TTM):
13.38%
Return On Equity:
17.42%
Return On Invested Capital:
12.28%
Operating Margin:
16.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.6B | $2.9B | $3.2B | $713.2M | $805.6M | |
| Gross Profit | $974.6M | $1.1B | $1.2B | $253.8M | $292.5M | |
| Operating Income | $441.5M | $505.9M | $573.6M | $100M | $130.5M | |
| EBITDA | $572.6M | $651.9M | $704.1M | $136.6M | $166.1M | |
| Diluted EPS | $8.04 | $9.71 | $11.24 | $1.99 | $2.68 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.3B | $1.4B | $1.7B | $1.8B | |
| Total Assets | $4B | $4.1B | $4.4B | $4.6B | $5B | |
| Current Liabilities | $734.8M | $800.3M | $672.2M | $858.3M | $953.9M | |
| Total Liabilities | $2.1B | $2.2B | $2.3B | $2.2B | $2.4B | |
| Total Equity | $1.8B | $1.8B | $2.1B | $2.4B | $2.6B | |
| Total Debt | $1.1B | $1.2B | $1.2B | $1.1B | $958.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $327.5M | $494.1M | $551.1M | -$45.6M | -$38.8M | |
| Cash From Investing | -$325.9M | -$37.1M | -$296.2M | -$12M | -$24.9M | |
| Cash From Financing | -$8.5M | -$248.7M | -$363.1M | -$7M | -$98.6M | |
| Free Cash Flow | $289.5M | $448M | $486.5M | -$57.7M | -$54.5M | |
CW
Sector
Market Cap
$16.6B
$602.8M
Price % of 52-Week High
97.15%
77.23%
Dividend Yield
0.19%
0%
Shareholder Yield
2.52%
2.32%
1-Year Price Total Return
57.68%
-3.86%
Beta (5-Year)
1.035
0.777
Dividend yield:
0.19%
Annualized payout:
$0.83
Payout ratio:
7.37%
Growth streak:
8 years
Technicals
8-day SMA
Buy
Level
$432.02
200-day SMA
Buy
Level
$344.93
Bollinger Bands (100)
Buy
Level
310.43 - 383.27
Chaikin Money Flow
Buy
Level
75M
20-day SMA
Buy
Level
$404.06
Relative Strength Index (RSI14)
Buy
Level
79.11
ADX Line
Buy
Level
44.28
Williams %R
Sell
Level
-15.6447
50-day SMA
Buy
Level
$355.16
MACD (12, 26)
Buy
Level
26.33
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
40.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.4281)
Buy
CA Score
(Annual)
Level (0.3099)
Buy
Beneish M-Score
(Annual)
Level (-2.4813)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.829)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems, weapons handling systems, pumps, valves, and other solutions. The company has three reportable segments based on the markets serviced: Naval & Power, which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems that also generate maximum revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics. Geographically, the company generates its key revenue from the United States of America, followed by the United Kingdom and other countries.
Stock Forecast FAQ
In the current month, CW has received 5 Buy ratings 3 Hold ratings, and 0 Sell ratings. The CW average analyst price target in the past 3 months is $408.26.
-
Where Will Curtiss-Wright Stock Be In 1 Year?
According to analysts, the consensus estimate is that Curtiss-Wright share price will drop to $408.26 per share over the next 12 months.
-
What Do Analysts Say About Curtiss-Wright?
Analysts are divided on their view about Curtiss-Wright share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Curtiss-Wright is a Sell and believe this share price will rise from its current level to $308.11.
-
What Is Curtiss-Wright's Price Target?
The price target for Curtiss-Wright over the next 1-year time period is forecast to be $408.26 according to 8 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is CW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Curtiss-Wright is a Buy. 5 of 8 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CW?
You can purchase shares of Curtiss-Wright via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Curtiss-Wright shares.
-
What Is The Curtiss-Wright Share Price Today?
Curtiss-Wright was last trading at $440.09 per share. This represents the most recent stock quote for Curtiss-Wright. Yesterday, Curtiss-Wright closed at $440.11 per share.
-
How To Buy Curtiss-Wright Stock Online?
In order to purchase Curtiss-Wright stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
